Can’t see any ramping tbh but valid point. Spread awful has been for a while was 30% a few days ago
Brilliant Post Ant - Thank You
Great post this ANT
Good Post Brighty
Agree in your statements - I mean the last presentation stated a £1m pipeline then the interims last week stated £1.5 m pipeline so it would indicate there is significant growth forecasted
You mean the 1.5 M revenues as per the interims results
The Directors believe the Company will continue to trade in line with market expectations.
Surely this is a 1.5Million pipeline therefore profitable by a few hundred k
The Company's pipeline of potential new business now stands at over £1.5m
How has Suzy dodged this one…..her role needs to be up there for a vote aswell…… maybe she knows the other three and has oceatrated the whole thing….. more time more money rinsed - smoke and mirrors - absolute scammers
How has Suzy dodged this one…..her role needs to be up there for a vote aswell…… maybe she knows the other three and has oceatrated the whole thing….. more time more money rinsed - smoke and mirrors - absolute scammers
I think this is automatic info sent out by the Investors meet company platform... to do these types of calls / presentations presumably they will have to book a slot and pay for this service
I note there is inconsistencies within the RNS - the last two are very different in the "About Physiomics Jazz" at the bottom.
I also note that why has the latest RNS got a "Question Mark ? " after virtual Tumour and CRUK has been droppped?
if this is merely a mistake then the attention to detail !!!!
RNS 1st March 2024
About Physiomics
Physiomics plc (AIM: PYC) is an oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions. The Company's Virtual Tumour? technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Physiomics' technologies have been confirmed by over 100 projects, involving over 50 targets and 75 drugs, and has worked with clients such as Merck KGaA, Astellas, Merck & Co and Bicycle Therapeutics.
RNS 19th February 2024
About Physiomics
Physiomics plc combines cutting edge PKPD and QSP modelling and data science techniques, along with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys.
Our approach is to derive insight from all relevant data in order to de-risk decision making and optimise design research across discovery, pre-clinical and clinical studies.
Through use of bespoke models and our proprietary Virtual Tumour technology, the Physiomics team has informed the development of over 100 commercial projects, over 50 targets and 75 drugs. Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK.
Interims will be next week I think.
Going wild another 33 lol
Needs to be questioned….
BOD of directors all used to work for the same company.
Val Lab PYC has an agreement with
Scientific Advisory Board Together.
All seems like they getting tighter…. VAL has been decimated (so have we mind) but doesn't give a good vibe
Was Global Senior Vice President and Head of Capital Solutions for Syneos Health
Syneos is where Dr Peter Sagenent and Dr Kumar used to work….
The relationship seems to be getting closer which I’m
Not sure is a good thing….
PYC needs to stay away from Val in my eyes……
Jim also stated that there would be an RNS about meeting / exceeding or not exceeding expectations???
There is zero volume - no one is interested- my concern is even a few more contracts and the price won’t move.
I’m not sure the BOD have an understanding of The market and also creating value for all.
I mean when did they last buy shares / exercise on options….
There is literally zero interest- not even people picking stock up at these lows. Volume is pretty much zero which is awful tbh
Even with a few new contracts what’s it going to do move to 1.60 then float back down again. The past two minimal contracts set it south.
Well there suppose to be a Investors meet company meeting next month as per previous announcement- obvs if there’s no further updates then the BOD will be shot to pieces after stating (contracts watch this space etc)
Let’s hope we get some contracts and it’s not just a load of BS like the BOD at VAL
I believe it a license you pay for annually, anywhere between 2-5k